We conduct research on GLP status in the field of development and validation of bioanalytical methods and their use for studying the toxico- and pharmacokinetics of drugs. In this aspect, research is carried out in accordance with the main domestic and international regulatory documents:
- Interstate standard GOST 33044-2014 "PRINCIPLES OF GOOD LABORATORY PRACTICE".
- Decision of the Council of the Eurasian Economic Commission dated November 3, 2016 N 85 “On approval of the Rules for conducting bioequivalence studies of medicinal products within the framework of the Eurasian Economic Union”.
- FDA Guidance for Industry: M10 Bioanalytical Method Validation and Study Sample Analysis, NOVEMBER 2022.